NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

Coenzyme Q10 的全球市場:各用途 - 地區預測,成長可能性,競爭市場佔有率,及預測(2019年∼2026年)

Coenzyme Q10 Market Size By Application (Pharmaceuticals, Dietary Supplements, Cosmetics) Industry Analysis Report, Regional Outlook, Application Potential, Covid-19 Impact Analysis, Price Trend, Competitive Market 2021- 2027

出版商 Global Market Insights Inc. 商品編碼 917754
出版日期 內容資訊 英文 160 Pages
商品交期: 2-3個工作天內
價格
Coenzyme Q10 的全球市場:各用途 - 地區預測,成長可能性,競爭市場佔有率,及預測(2019年∼2026年) Coenzyme Q10 Market Size By Application (Pharmaceuticals, Dietary Supplements, Cosmetics) Industry Analysis Report, Regional Outlook, Application Potential, Covid-19 Impact Analysis, Price Trend, Competitive Market 2021- 2027
出版日期: 2021年07月12日內容資訊: 英文 160 Pages
簡介

全球Coenzyme Q10 市場,預計2026年將超越10億美元的規模。由於出色的健康上的優點含CoQ10的營養補充品消費的增加,預計促進該市場的成長。

本報告提供全球Coenzyme Q10 市場的相關調查,市場趨勢,成長要素和課題,各用途、地區的市場分析,競爭情形,潛在客戶,主要企業的簡介等資訊。

目錄

第1章 調查方法、範圍

  • 調查方法
  • 市場定義
  • 市場預測、預測參數
  • 資訊來源
    • 一次
    • 二次

第2章 摘要整理

  • 產業概要
    • 事業趨勢
    • 地區
    • 用途

第3章 產業的考察

  • 產業市場區隔
  • 產業的展望
  • 產業生態系統分析
    • 供應商矩陣
    • 流通管道分析
  • 法規狀況
    • 歐洲
  • 成本結構分析
  • 技術的展望
  • 價格分析
  • 對產業的影響力
    • 成長要素
    • 產業的弱點、課題
  • 創新及永續性
  • 成長潛在力分析
    • 新的經營模式
  • 波特的五力分析
  • 競爭情形
    • 企業的市場佔有率分析
    • 策略儀表板
  • PESTEL分析

第4章 市場分析:各用途

  • 主要趨勢
  • 醫藥品
    • 全球市場(噸)(100萬美元)
    • 全球市場:各地區(噸)(100萬美元)
  • 減肥補給品
  • 化妝品
  • 其他

第5章 市場分析:各地區

  • 主要地區趨勢
  • 北美
    • 北美市場
    • 各用途
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲市場
    • 各用途
    • 德國
    • 英國
    • 法國
    • 義大利
    • 俄羅斯
    • 波蘭
  • 亞太地區
    • 亞太地區市場
    • 各用途
    • 中國
    • 印度
    • 日本
  • 南美
    • 南美市場
    • 各用途
    • 巴西
    • 墨西哥
  • 中東、非洲
    • 中東、非洲市場
    • 各用途
    • 南非
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯

第6章 企業簡介

  • Kaneka Corporation
  • DSM
  • SourceOne Global Partners, LLC
  • Healthy Origins
  • Vitamin Shoppe, Inc.
  • NBTY, Inc.
  • Pharmavite LLC
  • QUTEN Research Institute LLC
  • Tishcon Corp.
  • Country Life, LLC
  • Natural Organics
  • Jarrow Formulas
  • NOW Foods
  • Pharma Nord, Inc.
  • Doctor's Best
  • Xiamen Kingdomway Group
  • GNC Holdings, Inc.
  • Nordic Naturals, Inc.

第7章 潛在客戶

  • Merck & Co.
    • 事業概要
    • 財務資料
    • 產品的展望
  • Abbott Laboratories
  • Sun Pharmaceutical Industries Limited
  • Pfizer
  • Sanofi
  • Bristol Myers Squibb
  • Novartis
  • Johnson & Johnson
  • GlaxoSmithKline
  • Unilever
  • Avon Products, Inc
  • Beiersdorf
  • Henkel AG & Co., KGaA
  • Oriflame Holding AG
  • The Estée Lauder Companies Inc.
  • Yves Rocher
  • 株式會社資生堂
  • Bluebonnet Nutrition
  • Barlean's
  • Natural Factors
  • LifeExtension
目錄
Product Code: 741

The coenzyme Q10 market is anticipated to witness robust growth by 2027 driven by rising health consciousness among consumers across the globe. Moreover, growing awareness pertaining to the advantages of coenzyme Q10 dietary supplements is also projected to positively impact market dynamics through the forecast period.

Non-communicable diseases, such as cancer, diabetes, and neurodegenerative and cardiovascular diseases, are among the leading causes of death. These illnesses can be prevented by early detection, risk factor reduction, and adequate treatment.

A healthy diet, coupled with dietary supplementation, is considered vital in reducing morbidity and mitigating healthcare costs. Subsequently, due to the increasing emphasis on dietary supplementation, there is a surging need to fortify scientific backing pertaining to the safety and efficacy of a broad range of active ingredients. This has expanded the research focus on the use of ingredients like coenzyme Q10, thereby enhancing market outlook.

Coenzyme Q10 is the one of the most consumed dietary supplements and serves as a potential candidate in the treatment of several non-communicable diseases, which has propelled consumer interest considerably over the past decade. It is typically used for conditions that affect the heart, such as heart failure, chest pain, fluid buildup like in congestive heart failure (CHF), and high blood pressure. It is also utilized in the treatment of Parkinson's disease, migraine headaches, and other conditions.

Coenzyme Q10 supplementation has proven to be useful as an adjuvant in the treatment of cardiovascular illnesses like atrial fibrillation, myocardial infarction, and heart failure, and in associated risk factors, such as dyslipidemias, insulin resistance, hypertension, and obesity. Thus, significant health benefits of these supplements have been favorable for market expansion in key regions.

Following the COVID-19 outbreak, a drastic escalation in health consciousness has been witnessed among people across the globe. Furthermore, a healthy diet has proven to be useful in expediting the recovery of patients infected with the novel coronavirus, which has added emphasis on identifying food products and supplements that could aid in the treatment.

To that effect, a November 2020 study examined the effects of the COVID-19 infection on coenzyme Q10 in the body. The research findings concluded that COVID-19 patients could benefit from supportive targeting therapy with coenzyme Q10, which would augment energy production, improve immunity, and reduce oxidative stress. As a result, the increasing prominence of coenzyme Q10 supplements has massively contributed to industry revenue growth.

For detailed assessment, the coenzyme Q10 market has been segmented on the basis of application and region. With respect to region, the Latin America coenzyme Q10 market is expected to reach a valuation of around USD 17.5 million by the end of 2027, progressing at a steady CAGR through the projected timeline. Meanwhile, the Middle East and Africa coenzyme Q10 market is estimated to grow at a CAGR of approximately 6.0% over the forecast period.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates & working
    • 1.2.1 Forecast calculations
  • 1.3 Data Sources
    • 1.3.1 Primary
    • 1.3.2 Secondary
      • 1.3.2.1 Paid Sources
      • 1.3.2.2 Public Sources

Chapter 2 Executive Summary

  • 2.1 Global coenzyme Q10 industry 360 degree synopsis, 2021 - 2027
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Application trend

Chapter 3 Coenzyme Q

  • 3.1 Industry segmentation
  • 3.2 Impact of COVID-19 on world economy
  • 3.3 Industry ecosystem analysis
    • 3.3.1 Vendor matrix
    • 3.3.2 Distribution channel analysis
      • 3.3.2.1 Distributor
      • 3.3.2.2 Suppliers
      • 3.3.2.3 Contract Manufacturing
      • 3.3.2.4 Technology providers
  • 3.4 Raw material analysis: Covid-19 impact on supply
    • 3.4.1 Covid-19 impact on supply
  • 3.5 Industry landscape, 2016 - 2027
  • 3.6 Technology landscape
  • 3.7 Regulatory landscape
    • 3.7.1 Europe
  • 3.8 Pricing analysis
      • 3.8.1.1 Regional pricing: COVID-19 impact
      • 3.8.1.2 Cost structure analysis
  • 3.9 Industry impact forces
    • 3.9.1 Growth drivers
      • 3.9.1.1 North America: Growing demand for cosmetics product
      • 3.9.1.2 Europe: Increasing prevalence of diabetes and cardiovascular diseases
      • 3.9.1.3 Asia Pacific: Pharmaceutical market expansion leading to rising demand
    • 3.9.2 Industry pitfalls & challenges
      • 3.9.2.1 Minimum dosage requirement
  • 3.10 Innovation & sustainability
  • 3.11 Growth potential analysis, 2020
    • 3.11.1 Emerging business model
      • 3.11.1.1 New Product Launch
      • 3.11.1.2 Collaboration
  • 3.12 Porter's analysis
    • 3.12.1 Bargaining power of suppliers
    • 3.12.2 Bargaining power of buyers
    • 3.12.3 Threat of new entrants
    • 3.12.4 Threat of substitutes
  • 3.13 Competitive landscape, 2020
    • 3.13.1 Company market share analysis, 2020
    • 3.13.2 Top players overview
    • 3.13.3 Strategy dashboard
  • 3.14 PESTEL analysis
  • 3.15 COVID-19 impact on Coenzyme Q10 demand, by application
    • 3.15.1 Dietary Supplements
    • 3.15.2 Pharmaceuticals
    • 3.15.3 Cosmetics
    • 3.15.4 Others

Chapter 4 Coenzyme Q

  • 4.1 Key application trends
  • 4.2 Pharmaceuticals
    • 4.2.1 Global coenzyme Q10 market from pharmaceutical application, 2016-2026, (Tons) (USD Million)
    • 4.2.2 Global coenzyme Q10 market from pharmaceutical application, by region, 2016 - 2027, (Tons) (USD Million)
  • 4.3 Dietary Supplements
    • 4.3.1 Global coenzyme Q10 market from dietary supplements application, 2016 - 2027, (Tons) (USD Million)
    • 4.3.2 Global coenzyme Q10 market from dietary supplements application, by region, 2016 - 2027, (Tons) (USD Million)
  • 4.4 Cosmetics
    • 4.4.1 Global coenzyme Q10 market from cosmetics application, 2016 - 2027, (Tons) (USD Million)
    • 4.4.2 Global coenzyme Q10 market from cosmetics application, by region, 2016 - 2027, (Tons) (USD Million)
  • 4.5 Others
    • 4.5.1 Global coenzyme Q10 market from other application, 2016 - 2027, (Tons) (USD Million)
    • 4.5.2 Global coenzyme Q10 market from other application, by region, 2016 - 2027, (Tons) (USD Million)

Chapter 5 Coenzyme Q

  • 5.1 Key regional trends
  • 5.2 North America
    • 5.2.1 North America coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
    • 5.2.2 North America coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
    • 5.2.3 U.S.
      • 5.2.3.1 U.S. coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
      • 5.2.3.2 U.S. coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
    • 5.2.4 Canada
      • 5.2.4.1 Canada coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
      • 5.2.4.2 Canada coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
    • 5.3.2 Europe coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Germany coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
      • 5.3.3.2 Germany coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
    • 5.3.4 UK
      • 5.3.4.1 UK coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
      • 5.3.4.2 UK coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
    • 5.3.5 France
      • 5.3.5.1 France coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
      • 5.3.5.2 France coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
    • 5.3.6 Italy
      • 5.3.6.1 Italy coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
      • 5.3.6.2 Italy coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
    • 5.3.7 Russia
      • 5.3.7.1 Russia coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
      • 5.3.7.2 Russia coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
    • 5.3.8 Poland
      • 5.3.8.1 Poland coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
      • 5.3.8.2 Poland coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
    • 5.4.2 Asia Pacific coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
    • 5.4.3 China
      • 5.4.3.1 China coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
      • 5.4.3.2 China coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
    • 5.4.4 India
      • 5.4.4.1 India coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
      • 5.4.4.2 India coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
    • 5.4.5 Japan
      • 5.4.5.1 Japan coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
      • 5.4.5.2 Japan coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
  • 5.5 Latin America (LATAM)
    • 5.5.1 LATAM coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
    • 5.5.2 LATAM coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
    • 5.5.3 Brazil
      • 5.5.3.1 Brazil coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
      • 5.5.3.2 Brazil coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
    • 5.5.4 Mexico
      • 5.5.4.1 Mexico coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
      • 5.5.4.2 Mexico coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)
  • 5.6 Middle East & Africa (MEA)
    • 5.6.1 MEA coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
    • 5.6.2 MEA coenzyme Q10 market, by application, 2016 - 2027, (Tons) (USD Million)

Chapter 6 Company Profiles

  • 6.1 Kaneka Corporation
    • 6.1.1 Business Overview
    • 6.1.2 Financial Data
    • 6.1.3 Product Landscape
    • 6.1.4 SWOT Analysis
  • 6.2 DSM
    • 6.2.1 Business Overview
    • 6.2.2 Financial Data
    • 6.2.3 Product Landscape
    • 6.2.4 SWOT Analysis
  • 6.3 SourceOne Global Partners, LLC
    • 6.3.1 Business Overview
    • 6.3.2 Financial Data
    • 6.3.3 Product Landscape
    • 6.3.4 SWOT Analysis
  • 6.4 Healthy Origins
    • 6.4.1 Business Overview
    • 6.4.2 Financial Data
    • 6.4.3 Product Landscape
    • 6.4.4 SWOT Analysis
  • 6.5 Vitamin Shoppe, Inc.
    • 6.5.1 Business Overview
    • 6.5.2 Financial Data
    • 6.5.3 Product Landscape
    • 6.5.4 SWOT Analysis
  • 6.6 NBTY, Inc.
    • 6.6.1 Business Overview
    • 6.6.2 Financial Data
    • 6.6.3 Product Landscape
    • 6.6.4 SWOT Analysis
  • 6.7 Pharmavite LLC
    • 6.7.1 Business Overview
    • 6.7.2 Financial Data
    • 6.7.3 Product Landscape
    • 6.7.4 SWOT Analysis
  • 6.8 QUTEN Research Institute LLC
    • 6.8.1 Business Overview
    • 6.8.2 Financial Data
    • 6.8.3 Product Landscape
    • 6.8.4 SWOT Analysis
  • 6.9 Tishcon Corp.
    • 6.9.1 Business Overview
    • 6.9.2 Financial Data
    • 6.9.3 Product Landscape
    • 6.9.4 SWOT Analysis
  • 6.10 Country Life, LLC
    • 6.10.1 Business Overview
    • 6.10.2 Financial Data
    • 6.10.3 Product Landscape
    • 6.10.4 SWOT Analysis
  • 6.11 Natural Organics
    • 6.11.1 Business Overview
    • 6.11.2 Financial Data
    • 6.11.3 Product Landscape
    • 6.11.4 SWOT Analysis
    • 6.11.5 Strategic Outlook
  • 6.12 Jarrow Formulas
    • 6.12.1 Business Overview
    • 6.12.2 Financial Data
    • 6.12.3 Product Landscape
    • 6.12.4 SWOT Analysis
  • 6.13 NOW Foods
    • 6.13.1 Business Overview
    • 6.13.2 Financial Data
    • 6.13.3 Product Landscape
    • 6.13.4 SWOT Analysis
  • 6.14 Pharma Nord, Inc.
    • 6.14.1 Business Overview
    • 6.14.2 Financial Data
    • 6.14.3 Product Landscape
    • 6.14.4 SWOT Analysis
  • 6.15 Doctor's Best
    • 6.15.1 Business Overview
    • 6.15.2 Financial Data
    • 6.15.3 Product Landscape
    • 6.15.4 SWOT Analysis
    • 6.15.5 Strategic Outlook
  • 6.16 Xiamen Kingdomway Group
    • 6.16.1 Business Overview
    • 6.16.2 Financial Data
    • 6.16.3 Product Landscape
    • 6.16.4 SWOT Analysis
  • 6.17 GNC Holdings, Inc.
    • 6.17.1 Business Overview
    • 6.17.2 Financial Data
    • 6.17.3 Product Landscape
    • 6.17.4 SWOT Analysis
  • 6.18 Nordic Naturals, Inc.
    • 6.18.1 Business Overview
    • 6.18.2 Financial Data
    • 6.18.3 Product Landscape
    • 6.18.4 SWOT Analysis

Chapter 7 Potential Customers

  • 7.1 Merck & Co.
    • 7.1.1 Business Overview
    • 7.1.2 Financial Data
    • 7.1.3 Product Landscape
  • 7.2 Abbott Laboratories
    • 7.2.1 Business Overview
    • 7.2.2 Financial Data
    • 7.2.3 Product Landscape
  • 7.3 Sun Pharmaceutical Industries Limited
    • 7.3.1 Business Overview
    • 7.3.2 Financial Data
    • 7.3.3 Product Landscape
  • 7.4 Pfizer
    • 7.4.1 Business Overview
    • 7.4.2 Financial Data
    • 7.4.3 Product Landscape
  • 7.5 Sanofi
    • 7.5.1 Business Overview
    • 7.5.2 Financial Data
    • 7.5.3 Product Landscape
  • 7.6 Bristol Myers Squibb
    • 7.6.1 Business Overview
    • 7.6.2 Financial Data
    • 7.6.3 Product Landscape
  • 7.7 Novartis
    • 7.7.1 Business Overview
    • 7.7.2 Financial Data
    • 7.7.3 Product Landscape
  • 7.8 Johnson & Johnson
    • 7.8.1 Business Overview
    • 7.8.2 Financial Data
    • 7.8.3 Product Landscape
  • 7.9 GlaxoSmithKline
    • 7.9.1 Business Overview
    • 7.9.2 Financial Data
    • 7.9.3 Product Landscape
  • 7.10 Unilever
    • 7.10.1 Business Overview
    • 7.10.2 Financial Data
    • 7.10.3 Product Landscape
  • 7.11 Avon Products, Inc
    • 7.11.1 Business Overview
    • 7.11.2 Financial Data
    • 7.11.3 Product Landscape
  • 7.12 Beiersdorf
    • 7.12.1 Business Overview
    • 7.12.2 Financial Data
    • 7.12.3 Product Landscape
  • 7.13 Henkel AG & Co., KGaA
    • 7.13.1 Business Overview
    • 7.13.2 Financial Data
    • 7.13.3 Product Landscape
  • 7.14 Oriflame Holding AG
    • 7.14.1 Business Overview
    • 7.14.2 Financial Data
    • 7.14.3 Product Landscape
  • 7.15 The Estée Lauder Companies Inc.
    • 7.15.1 Business Overview
    • 7.15.2 Financial Data
    • 7.15.3 Product Landscape
  • 7.16 Yves Rocher
    • 7.16.1 Business Overview
    • 7.16.2 Financial Data
    • 7.16.3 Product Landscape
  • 7.17 Shiseido Company, Limited
    • 7.17.1 Business Overview
    • 7.17.2 Financial Data
    • 7.17.3 Product Landscape
  • 7.18 Bluebonnet Nutrition
    • 7.18.1 Business Overview
    • 7.18.2 Financial Data
    • 7.18.3 Product Landscape
  • 7.19 Barlean's
    • 7.19.1 Business Overview
    • 7.19.2 Financial Data
    • 7.19.3 Product Landscape
  • 7.20 Natural Factors
    • 7.20.1 Business Overview
    • 7.20.2 Financial Data
    • 7.20.3 Product Landscape
  • 7.21 LifeExtension
    • 7.21.1 Business Overview
    • 7.21.2 Financial Data
    • 7.21.3 Product Landscape

Data Tables

  • TABLE 1 Global coenzyme Q10 industry 360 degree synopsis, 2021 - 2027
  • TABLE 2 Global coenzyme Q10 market, 2016- 2027, (Tons) (USD Million)
  • TABLE 3 Global coenzyme Q10 market volume, by region, 2016 - 2027, (Tons)
  • TABLE 4 Global coenzyme Q10 market revenue, by region, 2016 - 2027, (USD Million)
  • TABLE 5 Global coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 6 Global coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 7 Vendor matrix
  • TABLE 8 CoQ10 distribution channel analysis
  • TABLE 9 Industry impact forces
  • TABLE 11 Global coenzyme Q10 market from pharmaceutical application, 2016 - 2027, (Tons) (USD Million)
  • TABLE 12 Global coenzyme Q10 market volume from pharmaceutical application, by region, 2016 - 2027, (Tons)
  • TABLE 13 Global coenzyme Q10 market revenue from pharmaceutical application, by region, 2016 - 2027, (USD Million)
  • TABLE 14 Global coenzyme Q10 market from dietary supplements application, 2016 - 2027, (Tons) (USD Million)
  • TABLE 15 Global coenzyme Q10 market volume from dietary supplements application, by region, 2016 - 2027, (Tons)
  • TABLE 16 Global coenzyme Q10 market revenue from dietary supplements application, by region, 2016 - 2027, (USD Million)
  • TABLE 17 Global coenzyme Q10 market from cosmetics application, 2016 - 2027, (Tons) (USD Million)
  • TABLE 18 Global coenzyme Q10 market volume from cosmetics application, by region, 2016 - 2027, (Tons)
  • TABLE 19 Global coenzyme Q10 market revenue from cosmetics application, by region, 2016 - 2027, (USD Million)
  • TABLE 20 Global coenzyme Q10 market from other application, 2016 - 2027, (Tons) (USD Million)
  • TABLE 21 Global coenzyme Q10 market volume from other application, by region, 2016 - 2027, (Tons)
  • TABLE 22 Global coenzyme Q10 market revenue from other application, by region, 2016 - 2027, (USD Million)
  • TABLE 23 North America coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 24 North America coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 25 North America coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 26 U.S. coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 27 U.S. coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 28 U.S. coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 29 Canada coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 30 Canada coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 31 Canada coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 32 Europe coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 33 Europe coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 34 Europe coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 35 Germany coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 36 Germany coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 37 Germany coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 38 UK coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 39 UK coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 40 UK coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 41 France coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 42 France coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 43 France coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 44 Italy coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 45 Italy coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 46 Italy coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 47 Russia coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 48 Russia coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 49 Russia coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 50 Poland coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 51 Poland coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 52 Poland coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 53 Asia Pacific coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 54 Asia Pacific coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 55 Asia Pacific coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 56 China coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 57 China coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 58 China coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 59 India coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 60 India coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 61 India coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 62 Japan coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 63 Japan coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 64 Japan coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 65 LATAM coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 66 LATAM coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 67 LATAM coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 68 Brazil coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 69 Brazil coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 70 Brazil coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 71 Mexico coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 72 Mexico coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 73 Mexico coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)
  • TABLE 74 MEA coenzyme Q10 market, 2016 - 2027, (Tons) (USD Million)
  • TABLE 75 MEA coenzyme Q10 market volume, by application, 2016 - 2027, (Tons)
  • TABLE 76 MEA coenzyme Q10 market revenue, by application, 2016 - 2027, (USD Million)

Charts & Figures

  • FIG. 1 Global heart conditions & statistics, 2017, (% share)
  • FIG. 2 Global cosmetic market share by category, 2017, (% share)
  • FIG. 3 Europe cosmetic market by country, 2017, (USD billion)
  • FIG. 4 Industry segmentation
  • FIG. 5 Industry ecosystem analysis
  • FIG. 6 Global CoQ10 market estimates and forecast, 2016- 2027 (Tons) (USD Million)
  • FIG. 7 Coenzyme Q10 technology landscape
  • FIG. 8 Lactobacilli price trends (USD/kilo)
  • FIG. 9 North America cosmetics market, 2018, (USD Million)
  • FIG. 10 Europe diabetes data, 2017, (% share)
  • FIG. 11 Europe attributable factors risk factors for CVD, 2018, (% share)
  • FIG. 12 Asia Pacific pharmaceutical market, 2015-2026, (USD Billion)
  • FIG. 13 Growth potential analysis, 2020
  • FIG. 14 Porter's analysis
  • FIG. 15 Company market share analysis, 2020
  • FIG. 16 PESTEL analysis
  • FIG. 17 SWOT Analysis, Kaneka Corporation
  • FIG. 18 SWOT Analysis, DSM
  • FIG. 19 SWOT Analysis, SourceOne Global Partners
  • FIG. 20 SWOT Analysis, Healthy Origins
  • FIG. 21 SWOT Analysis, Vitamin Shoppe, Inc.
  • FIG. 22 SWOT Analysis, Nature's Bounty Co.
  • FIG. 23 SWOT Analysis, Pharmavite LLC
  • FIG. 24 SWOT Analysis, Quten Research Institute
  • FIG. 25 SWOT Analysis, Tishcon Corp
  • FIG. 26 SWOT Analysis, Country Life, LLC
  • FIG. 27 SWOT Analysis, Natural Organics
  • FIG. 28 SWOT Analysis, Jarrow Formulas
  • FIG. 29 SWOT Analysis, NOW Foods
  • FIG. 30 SWOT Analysis, Pharma Nord
  • FIG. 31 SWOT Analysis, Doctor's Best, Inc.
  • FIG. 32 SWOT Analysis, Xiamen Kingdomway Group
  • FIG. 33 SWOT Analysis, GNC Holdings, Inc.
  • FIG. 34 SWOT Analysis, Nordic Naturals, Inc.